ISPOR Board of Directors Approves New Diversity and Inclusion Policy

Lawrenceville, NJ, USA—June 11, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the approval of the Society’s new Diversity and Inclusion Policy.

Read more ›
Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: , , ,

ISPOR Announces 2019-2020 Board of Directors

Nancy J. Devlin, PhD Moves Into the Role of President

Lawrenceville, NJ, USA—June 10, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the results of its recent elections and its 2019-2020 Board of Directors. The Society’s membership selects its new president-elect and the 2019-2020 board will assume office on July 1, 2019.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR 2019 Convened Nearly 4000 Healthcare Stakeholders

Conference Focused on the Future of HEOR

New Orleans, LA, USA—May 23, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), recently concluded its ISPOR 2019 annual conference in New Orleans, LA, USA. The conference convened nearly 4000 healthcare stakeholders representing more than 65 countries and from all sectors of healthcare, including policy makers, global thought leaders, researchers and academicians, public and private payers, healthcare providers, and patient engagement organizations. The conference centered on the timely theme, “Rapid. Disruptive. Innovative. A New Era in HEOR,” and addressed a wide variety of compelling topics in HEOR.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR Wins Multiple Hermes Creative Awards

The Society Was Recognized for Its Rebranding Campaign, Website Redesign, and “Top 10 HEOR Trends” Horizon Scanning Report

Lawrenceville, NJ, USA—May 23, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR)—has won 6 Platinum and Gold level Hermes Awards for its rebranding campaign, website redesign, and “2019 Top 10 HEOR Trends” report.

Read more ›
Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: , ,

Patient Access and Biosimilars

New Orleans, LA, USA—May 22, 2019ISPOR the professional society for health economics and outcomes research (HEOR), examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference with the session [W20], “Improving Patient Access to Life Saving Therapies: What Needs to Be Done to Fulfill the Promise of Biosimilars?”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,

Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?

The Explosion of Innovative, New Therapies and Payers’ Crisis of Affordability

New Orleans, LA, USA—May 22, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), held its final plenary of the ISPOR 2019 annual conference with, “Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , ,

High Healthcare Costs in the United States—Could Formal Health Technology Assessment Be a Solution?

New Orleans, LA, USA—May 22, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), explored the possibility of health technology assessment (HTA) in the United States this morning at its ISPOR 2019 annual conference with the session [IP26], “Could Formal HTA Be a Solution to High Healthcare Costs in the United States?”

The United States has the highest healthcare costs per person in the world. HTA is often seen as a method for drug cost control; however, the US healthcare system lacks a national HTA body with a formal mandate and binding authority. A number of differences in the US healthcare system complicate the issue, such as reimbursement structures, stakeholder incentives, and a pluralistic payer system. The United States’ notable absence of an HTA body contrasts markedly with other countries where healthcare is more affordable. The increase in the number of institutions in the United States that are developing value frameworks for assessment of therapies could signal a greater willingness to accept formal HTA as part of reimbursement.

Panelists for the session included:

  • Wrik Ghosh, MSc; Costello Medical Singapore Pte Ltd; Singapore
  • Sarah Breen, MA, MSc; MSD UK; Hoddesdon, England, UK
  • Thomas Butt, PhD; Peking University; Beijing, China
  • Daniel A. Ollendorf, PhD; Tufts Medical Center; Boston, MA, USA

Dr Ollendorf provided an HTA perspective, comparing the efforts made by the Institute for Clinical and Economic Review (ICER) in the United States to those abroad, highlighting feasible options. Dr Butt offered an international perspective, discussing whether the United States can learn from countries that have successfully implemented HTA or whether there are higher priorities for US healthcare system. Ms Breen offered a manufacturer perspective, noting that formal HTA could present a threat to manufacturers’ profits and change incentives, but could also provide opportunities to demonstrate value and improve patient access.

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and its role in improving healthcare decisions. ISPOR 2019 is the leading global HEOR conference and draws nearly 4000 healthcare thought leaders and stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program | Registration | Short Course Program | Sponsors | Exhibitors | Press

###

ABOUT ISPOR

ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

Women in Health Economics and Outcomes Research Initiative Convenes at ISPOR 2019

Session Featured Guest Speaker Renée Arnold

New Orleans, LA, USA—May 22, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), held a session for its Women in HEOR initiative yesterday late afternoon at its ISPOR 2019 annual conference in New Orleans, LA, USA. ISPOR launched this initiative in late 2017 with the vision to support the growth, development, and contribution of women in HEOR; to serve as a catalyst for women’s leadership in the field; and to offer a platform for ISPOR women to collaborate, network, share, and mentor each other.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,

Improving Real-World Evidence in Healthcare With Patient-Provided Information

New Orleans, LA, USA—May 21, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), examined how real-world evidence can be improved with patient-provided information this afternoon at its ISPOR 2019 annual conference with the session [W13], “Leveraging Patient-Provided Information to Improve Real-World Evidence: Getting to Good Practices on How.”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , , ,

The Future of Health Economics and Outcomes Research

A Forecast For HEOR in the 2020s

New Orleans, LA, USA—May 21, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), explored the future of HEOR for the 2020s this afternoon at its ISPOR 2019 annual conference with the session [IP18], “Gazing Into the HEOR Crystal Ball: What Might Be the Future Directions for HEOR in the 2020s?”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,